Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVO crawled time : 12:30 save search
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
conference therapeutics
Novo Nordisk files annual report with the SEC
Published: 2024-01-31 (Crawled : 12:30) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 2.87%
H: 3.54%
C: 2.31%
report
Novo Nordisk A/S - share repurchase programme
Published: 2023-12-04 (Crawled : 12:30) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 0.17%
H: 0.57%
C: 0.35%
repurchase
energyRe Announces $1.2 Billion Capital Raise to Accelerate U.S. Clean Energy Transition
Published: 2023-12-04 (Crawled : 12:30) - prnewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 0.17%
H: 0.57%
C: 0.35%
energy
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Published: 2023-11-28 (Crawled : 12:30) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: -1.93%
H: 0.37%
C: -0.43%
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: -3.39%
H: 0.7%
C: -6.49%
PODD | $164.46 -1.08% -1.09% 680K
|
Health Technology
|
| O: -0.87%
H: 1.19%
C: -0.21%
biotech financial
Novo Nordisk A/S – Share repurchase programme
Published: 2022-03-21 (Crawled : 12:30) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 1.26%
H: 1.23%
C: 0.08%
program
BioSpace Movers & Shakers: Enveda, Evaxion, Elevation
Published: 2022-03-18 (Crawled : 12:30) - biospace.com/
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
SPRB | News | $0.6901 -1.47% -1.49% 450K
|
Health Technology
|
| O: 0.98%
H: 5.69%
C: -2.91%
KMDA | $5.05 -0.99% 8K
|
Health Technology
|
| O: -0.17%
H: 2.62%
C: 2.08%
HMST | $12.45 -1.81% -1.85% 100K
|
Finance
|
| O: -0.66%
H: 0.0%
C: -2.24%
BRKR | $78.035 0.35% 0.35% 810K
|
Health Technology
|
| O: -0.33%
H: 2.52%
C: 2.19%
space spac
Novo Nordisk A/S – Share repurchase programme
Published: 2022-03-14 (Crawled : 12:30) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
program
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2022
Published: 2022-01-24 (Crawled : 12:30) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: -10.12%
H: 1.05%
C: 1.05%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: -1.88%
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: -3.36%
H: 3.08%
C: 2.84%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -2.45%
H: 0.18%
C: -0.02%
IPHA | $2.28 -6.56% -7.02% 9.5K
|
Health Technology
|
| O: -4.85%
H: 0.26%
C: -5.36%
pharma
2seventy bio Announces Expanded Collaboration Agreement With Novo Nordisk to Continue Development of in vivo Gene Editing Approach
Published: 2022-01-06 (Crawled : 12:30) - biospace.com/
TSVT | $4.67 3.32% 3.21% 410K
|
|
| O: 5.11%
H: 6.69%
C: 4.86%
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: -3.91%
H: 3.22%
C: 2.12%
ces collaboration
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.